The Latest Technology for
preventing and treating life-threatening human diseases.
At Ansun, we are committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients.
Our COVID-19 Response
Ansun Biopharma used its influenza research data to dive into attempts to develop a treatment for COVID-19 using an investigational nebulized enzyme asset as a potential treatment for severely infected patients.
